Paul W Hawran - Net Worth and Insider Trading
Paul W Hawran Net Worth
The estimated net worth of Paul W Hawran is at least $46 Million dollars as of 2024-11-13. Paul W Hawran is the Executive VP and CFO of Neurocrine Biosciences Inc and owns about 360,144 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $46 Million. Paul W Hawran is also the Director of Plus Therapeutics Inc and owns about 10 shares of Plus Therapeutics Inc (PSTV) stock worth over $13. Details can be seen in Paul W Hawran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul W Hawran has not made any transactions after 2011-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul W Hawran
Paul W Hawran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul W Hawran owns 3 companies in total, including Plus Therapeutics Inc (PSTV) , Sequenom Inc (SQNM) , and Neurocrine Biosciences Inc (NBIX) .
Click here to see the complete history of Paul W Hawran’s form 4 insider trades.
Insider Ownership Summary of Paul W Hawran
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2011-09-14 | director |
| SQNM | Sequenom Inc | 2009-03-13 | Chief Financial Officer |
| NBIX | Neurocrine Biosciences Inc | 2006-05-17 | Executive VP and CFO |
Paul W Hawran Latest Holdings Summary
Paul W Hawran currently owns a total of 2 stocks. Among these stocks, Paul W Hawran owns 360,144 shares of Neurocrine Biosciences Inc (NBIX) as of May 17, 2006, with a value of $46 Million and a weighting of 100%. Paul W Hawran also owns 10 shares of Plus Therapeutics Inc (PSTV) as of September 14, 2011, with a value of $13 and a weighting of 0%.
Latest Holdings of Paul W Hawran
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2006-05-17 | 360,144 | 127.04 | 45,752,694 |
| PSTV | Plus Therapeutics Inc | 2011-09-14 | 10 | 1.29 | 13 |
Holding Weightings of Paul W Hawran
Paul W Hawran Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul W Hawran has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 115,481 shares on May 17, 2006, which brought Paul W Hawran around $2 Million.
According to the SEC Form 4 filings, Paul W Hawran has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 1 shares on September 14, 2011, which cost Paul W Hawran around $16,000.
Insider Trading History of Paul W Hawran
- 1
Paul W Hawran Trading Performance
GuruFocus tracks the stock performance after each of Paul W Hawran's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul W Hawran is 40.52%. GuruFocus also compares Paul W Hawran's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul W Hawran within 3 months outperforms 6 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul W Hawran's insider trading performs compared to the benchmark.
Performance of Paul W Hawran
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.73 | | | | | |
| Relative Return to S&P 500(%) | 22.94 | | | | | |
Paul W Hawran Ownership Network
Ownership Network List of Paul W Hawran
Ownership Network Relation of Paul W Hawran
Paul W Hawran Owned Company Details
What does Plus Therapeutics Inc do?
Who are the key executives at Plus Therapeutics Inc?
Paul W Hawran is the director of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .
Plus Therapeutics Inc (PSTV) Insider Trades Summary
Over the past 18 months, Paul W Hawran made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 28,761 shares made by Robert P Lenk , a net purchase of 22,797 shares made by Howard Clowes , and a net purchase of 44,755 shares made by Greg Petersen .
In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 39,883 shares, with a net purchase of 39,883 shares. During the past 18 months, 2,068 shares of Plus Therapeutics Inc (PSTV) were sold and 140,755 shares were bought by its insiders, resulting in a net purchase of 138,687 shares.
Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Plus Therapeutics Inc Insider Transactions
Paul W Hawran Mailing Address
Above is the net worth, insider trading, and ownership report for Paul W Hawran. You might contact Paul W Hawran via mailing address: 3595 John Hopkins Court, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
